Metrics as of 10/17/2026, 04:56 AM (Berlin time), refresh in progress.
High Tide Stock
High Tide Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Country
- Canada
- CEO
- Harkirat Grover
- Employees
- 1,832
- Market cap
- $229 M
- IPO
- 08/01/2021
High Tide Inc. primarily operates as a prominent cannabis retailer with a significant presence across Canada, Europe, the United States, and other international markets. Beyond its retail footprint, the company is actively involved in the design, manufacturing, and distribution of smoking accessories and a variety of…
High Tide stock: price history
1D
+0.4%
1W
-1.5%
1M
-4.5%
6M
+5.8%
YTD
-3.0%
1Y
-25.3%
2Y
+3.2%
5Y
-54.5%
10Y
–
Next earnings date
Next earnings date
04/02/2027 (in 110 days)
Volatility around earnings
~15% weaker price swings than usual
Ask the agents about High Tide
Analyst assessment of High Tide
PRICE TARGET LOW
US$2.70
CONSENSUS
US$2.70
MEDIAN
US$2.70
PRICE TARGET HIGH
US$2.70
0
STRONG BUY
3
BUY
1
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 19/03/2026
High Tide stock metrics
P/E
-9.59
P/B
3.03
EV/EBITDA
95.25
RETURN ON EQUITY
10.8%
NET MARGIN
5.7%
DEBT/EQUITY
1.17
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
87.4%
FLOAT SHARES
77,924,717
AVG. DAILY VOLUME (30D)
818,636
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about High Tide stock
What does High Tide do?
High Tide Inc. is a company in the Healthcare sector, Medical - Pharmaceuticals industry, headquartered in Canada.
The CEO is Harkirat Grover, the company employs around 1,832 people.
The IPO was on 08/01/2021; the stock trades on NASDAQ under the ticker HITI.
What do analysts say about High Tide stock?
4 analysts rate the stock, the consensus is Buy (as of 19/03/2026).
The average price target is US$2.70, ranging from US$2.70 to US$2.70, with a median of US$2.70.
This is an external assessment, not a statement by Market Jury.
When does High Tide report next?
The next earnings date is 04/02/2027.
Around past earnings, price swings were roughly -15% stronger than usual.
Does High Tide pay a dividend?
No, High Tide currently does not pay a dividend.
Which stocks are comparable to High Tide?
Comparable stocks include Helus Pharma, Corcept Therapeutics, Liquidia, Latigo Biotherapeutics, Bausch + Lomb, AbCellera Biologics, Eli Lilly and Company and Johnson & Johnson.
How can I get High Tide stock analyzed?
Clicking "Analyze stock" lets five strategies assess High Tide against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.